United States Small Bone and Joint Devices Market

United States Small Bone and Joint Devices Market Size and Share:

The United States small bone and joint devices market size was valued at USD 1.20 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 1.90 Billion by 2033, exhibiting a CAGR of 5.30% during 2025-2033. The market is witnessing consistent growth, supported by advances in technology, growing sports injuries, and rising geriatric orthopedic conditions. Procedural innovations in minimally invasive treatments, 3D printing, and biocompatible materials are improving treatment outcomes. Widening outpatient care and increased healthcare spending further enhance adoption across geographies. With the amplified need for specialized implants and surgery, the market keeps changing, illustrating strong opportunities for stakeholders. All these aspects collectively determine the United States small bone and joint devices market share.

The rising number of cases of sports injuries and trauma is also an essential factor driving the United States small bone and joint devices. With greater involvement in professional and recreational athletics, the incidence of fractures, ligament sprains, and joint dislocations has increased, generating a significant need for sophisticated orthopedic devices. Middle-aged and younger persons involved in high-impact sports frequently need surgical correction with specialized small bone and joint equipment to regain motion and function. Also adding to the demand for successful implants and fixation devices are the increase in road accidents and trauma admissions. Hospitals and surgery clinics make greater use of technology-driven devices to achieve faster recovery and avoid post-operative complications. The amplifying demand for minimally invasive orthopedic treatments by active patients further increases the demand for new devices. This trend highlights how the prevalence of accidents and lifestyle shifts are influencing market demand throughout the United States.

Another driver for United States small bone and joint devices market growth is the intensifying focus on ambulatory and outpatient surgical care. Healthcare delivery models are shifting towards procedures outside of traditional hospitals based on cost containment, patient convenience, and better outcomes. Ambulatory surgery centers are increasingly embracing sophisticated orthopedic equipment that accommodates minimally invasive procedures, shorter lengths of stay, and quicker rehabilitation. This shift has increased availability of specialized joint and bone treatment to a broader population base, allowing for quicker turnaround for surgeries and minimizing hospital stays. Additionally, insurers and providers are encouraging outpatient orthopedic procedures as a strategy to reduce the cost of total treatment while retaining high levels of care. The use of next-generation devices intended for use in these environments improves patient satisfaction and increases the efficiency of procedures. These trends are supporting demand for small bone and joint devices throughout the United States

United States Small Bone and Joint Devices Market Trends:

Technological developments

Advances in technology are a key driver in the small bone and joint devices market. Advances in materials science, robotics, and imaging technologies have greatly improved the efficacy and accuracy of orthopedic devices. For instance, advances in biocompatible materials like advanced polymers and ceramics have enhanced implant durability and integration with bone tissue. Additionally, continued innovations in MIS technology, including arthroscopy and robotic surgery, have decreased recovery times and enhanced patient outcomes. In addition to this, the incorporation of 3D printing technology enables the ability to customize implants and meet the particular anatomical requirements of unique patients, which increases the fit and function of devices, thereby contributing to the growth in the market. Global 3D printing market size was USD 28.5 Billion in 2024 and estimated to reach USD 125.9 Billion by 2033, as per the IMARC GROUP.

Aging population

As per United States small bone and joint devices market analysis, the shift in demographics towards an aging population is one of the major drivers for the expansion of the small bone and joint devices market. As people get older, there is increased frequency of orthopedic conditions like osteoarthritis, osteoporosis, and fractures. Based on the World Health Organization (WHO), by 2050, the world's elderly population of 60 years and above will double to 2.1 Billion, significantly raising the incidence of age-related orthopedic conditions. The older population is more prone to bone and joint diseases because of natural degenerative changes in bone density and joint flexibility over time. This increasing incidence of age-related orthopedic conditions fuels the need for small bone and joint devices since these patients tend to need surgical interventions to control their conditions and enhance the quality of their lives. In addition, the aging population is more inclined to pursue advanced medical interventions and becomes more tolerant of new technology and devices that provide improved functionality and shorten recovery times, which is driving the market.

Increasing healthcare spending

Growing healthcare spending in the United States is driving the growth of the market for small bone and joint devices. Greater healthcare spending allows patients and providers access to new orthopedic technologies and surgical procedures. A report indicates that U.S. health care spending increased by 7.5% to almost USD 5 Trillion in 2024, facilitating greater access to advanced orthopedic technologies and surgical procedures. Higher spending enables the innovation and use of new devices and methods of surgery. Also, with comprehensive healthcare policies and insurance plans, patients can afford and undergo the latest bone and joint devices. This has increased the availability and use of advanced orthopedic solutions, enhancing market growth. In addition to this, the rising focus on enhancing healthcare infrastructure and increasing access to specialized treatment is also contributing towards market growth.

United States Small Bone and Joint Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the United States small bone and joint devices market, along with forecasts at the regional levels from 2025-2033. The market has been categorized based on device type and end user.

Analysis by Device Type:

• Hand and Wrist Devices
• Foot and Ankle Devices
• Others

Hand and wrist devices represent a significant segment of the small bone and joint devices market, addressing conditions such as carpal tunnel syndrome, fractures, arthritis, and traumatic injuries. These devices include plates, screws, pins, wires, and specialized implants designed for the complex anatomy of hand and wrist structures. The growing prevalence of repetitive strain injuries and workplace-related hand trauma drives demand in this segment.

Foot and ankle devices cater to a wide range of conditions including fractures, deformities, arthritis, and sports-related injuries. This segment encompasses various fixation devices, joint replacement systems, and corrective implants. The increasing participation in sports and recreational activities, combined with an aging population prone to foot and ankle problems, contributes to segment growth.

The "Others" category includes devices for various small bones and joints throughout the body, such as elbow, shoulder (small components), and other specialized applications. This segment benefits from continuous innovation in device design and materials, addressing niche medical needs and rare conditions.

Analysis by End User:

• Hospitals
• Clinic
• Others

Hospitals serve as the primary end-user segment, equipped with comprehensive surgical facilities, specialized orthopedic departments, and emergency trauma centers. These institutions handle complex cases requiring advanced surgical interventions and have the infrastructure to support innovative device technologies. The hospital segment benefits from higher patient volumes and the ability to perform both routine and complex procedures.

Clinic, including ambulatory surgical centers and specialized orthopedic clinics, represent a growing segment driven by the trend toward outpatient care and cost-effective treatment options. These facilities focus on less complex procedures and routine interventions, offering patients convenient access to specialized care with shorter recovery times and reduced costs.

The "Others" category encompasses rehabilitation centers, sports medicine facilities, and other healthcare providers that utilize small bone and joint devices in their treatment protocols. This segment benefits from the expanding scope of orthopedic care beyond traditional surgical settings.

Regional Analysis:

• Northeast
• Midwest
• South
• West

The Northeast region, including states like New York, Massachusetts, and Pennsylvania, represents a mature market with established healthcare infrastructure and high healthcare spending. The region benefits from leading medical institutions, research centers, and a concentration of orthopedic specialists.

The Midwest region shows steady growth driven by an aging population and expanding healthcare access. States like Illinois, Ohio, and Michigan have significant healthcare systems that support orthopedic device adoption.

The South region represents a rapidly growing market due to population growth, expanding healthcare infrastructure, and increasing healthcare investments. States like Texas, Florida, and Georgia are experiencing significant market expansion.

The West region, including California, Washington, and Colorado, benefits from technological innovation, advanced healthcare systems, and higher healthcare spending per capita. This region often leads in adopting new technologies and innovative treatment approaches.

Competitive Landscape:

Firms are focusing on R&D in advanced biomaterials, minimally invasive surgical devices, and patient-specific implants to enhance the outcome of procedures and lower recovery times. The growing partnership among developers of medical technology, research establishments, and health care providers has consolidated product pipelines and hastened commercialization of next-generation products. Besides this, companies are also increasing their presence in outpatient as well as ambulatory surgical centers, as a function of the intensifying transformation in healthcare delivery models. Strategic initiatives like product launches, collaborations, as well as investments in digital platforms are facilitating organizations to boost their market share and meet increasing demand. With strong research and development, coupled with increasing applications in trauma, sports medicine, and geriatric care, the United States small bone and joint devices market forecast is for continued growth, bolstered by advancing technologies and changing clinical demands.

The report provides a comprehensive analysis of the competitive landscape in the United States small bone and joint devices market with detailed profiles of all major companies.

Latest News and Developments:

• July 2025: Enovis Corporation announced the launch of its Manafuse® Bone Growth Stimulator. This new addition to Enovis' portfolio of regenerative bone growth stimulation devices is clinically proven to accelerate the healing of indicated acute fractures by 38%. The device aims to improve musculoskeletal fracture healing times and enhance patient outcomes.
• May 2025: Osteoboost Health, Inc. announced the nationwide availability of Osteoboost, the first-ever drug-free prescription wearable device for treating low bone density. The FDA-cleared Class II De Novo Breakthrough Device is specifically designed for postmenopausal women with osteopenia. Osteoboost uses patented vibration therapy to target the spine and hips, areas at highest risk of fractures. During its pre-order phase, over 1,000 unique physicians prescribed the device. The launch is supported by new investments from AARP, Harvard Business School Angels, and Esplanade Ventures. This innovation fills a critical treatment gap for more than 60 million Americans facing low bone density.
• July 2025: Orthofix announced the US commercial launch of the Fitbone Transport and Lengthening System. This innovative technology will be showcased at the 2025 Limb Lengthening and Reconstruction Society Annual Meeting in Philadelphia later this week.

United States Small Bone and Joint Devices Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States small bone and joint devices market from 2019-2033
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States small bone and joint devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States small bone and joint devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.